Testosterone, cardiovascular disease and the metabolic syndrome
Authors:
- Giulia RastrelliGRGiulia Rastrelli
- Linda VignozziLVLinda Vignozzi
- Edoardo MannucciEMEdoardo Mannucci
- Mario MaggiMMMario Maggi
- 1 April 2011
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 25 (2) , 337-353
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndromeJournal of Endocrinological Investigation, 2010
- Reduced testosterone levels in males with lone atrial fibrillationClinical Cardiology, 2009
- Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancerCancer, 2008
- Relationship Between Low Levels of Anabolic Hormones and 6-Year Mortality in Older MenThe Aging in the Chianti Area (InCHIANTI) StudyArchives of internal medicine (1960), 2007
- Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancerCancer, 2007
- Sex Steroids and All-Cause and Cause-Specific Mortality in MenArchives of internal medicine (1960), 2007
- Low Serum Testosterone and Mortality in Male VeteransArchives of internal medicine (1960), 2006
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Sex hormone concentrations in men with angiographically assessed coronary artery disease — Relationship to obesity and body fat distributionJournal of Molecular Medicine, 1991
- Plasma Levels of Estradiol, Testosterone, and DHEAS Do Not Predict Risk of Coronary Artery Disease in MenJournal of Andrology, 1990